BNP Paribas Financial Markets Takes $590,000 Position in Oscar Health, Inc. (NYSE:OSCR)

BNP Paribas Financial Markets purchased a new position in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 43,873 shares of the company's stock, valued at approximately $590,000.

Several other institutional investors have also recently added to or reduced their stakes in the stock. Barclays PLC grew its holdings in Oscar Health by 217.5% during the 3rd quarter. Barclays PLC now owns 325,818 shares of the company's stock worth $6,911,000 after acquiring an additional 223,189 shares in the last quarter. Janney Montgomery Scott LLC lifted its position in shares of Oscar Health by 24.2% during the fourth quarter. Janney Montgomery Scott LLC now owns 57,850 shares of the company's stock worth $778,000 after purchasing an additional 11,282 shares during the last quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management lifted its position in shares of Oscar Health by 28.2% during the fourth quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 21,968 shares of the company's stock worth $295,000 after purchasing an additional 4,838 shares during the last quarter. KBC Group NV grew its stake in Oscar Health by 56.1% in the fourth quarter. KBC Group NV now owns 7,107 shares of the company's stock worth $96,000 after purchasing an additional 2,555 shares in the last quarter. Finally, GDS Wealth Management increased its holdings in Oscar Health by 1,545.3% in the fourth quarter. GDS Wealth Management now owns 345,817 shares of the company's stock valued at $4,648,000 after buying an additional 324,798 shares during the last quarter. 75.70% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other news, Director Elbert O. Jr. Robinson sold 25,000 shares of the business's stock in a transaction that occurred on Monday, May 12th. The stock was sold at an average price of $16.43, for a total transaction of $410,750.00. Following the completion of the transaction, the director now directly owns 64,512 shares in the company, valued at approximately $1,059,932.16. The trade was a 27.93% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Corporate insiders own 24.39% of the company's stock.

Analyst Ratings Changes

A number of research analysts have commented on OSCR shares. Wall Street Zen downgraded Oscar Health from a "buy" rating to a "hold" rating in a report on Thursday, May 22nd. Wells Fargo & Company lowered Oscar Health from an "overweight" rating to an "equal weight" rating and dropped their price target for the company from $20.00 to $16.00 in a research report on Thursday, March 13th. Two investment analysts have rated the stock with a sell rating, three have assigned a hold rating, two have given a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat, the company has an average rating of "Hold" and a consensus target price of $20.08.

Oscar Health Stock Performance

OSCR stock traded up $0.86 during midday trading on Tuesday, reaching $15.03. The company had a trading volume of 8,061,517 shares, compared to its average volume of 4,326,438. The firm has a market capitalization of $3.77 billion, a PE ratio of -751.12 and a beta of 1.75. The stock has a 50 day moving average price of $13.68 and a 200 day moving average price of $14.59. Oscar Health, Inc. has a fifty-two week low of $11.20 and a fifty-two week high of $23.79. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.26.

Oscar Health (NYSE:OSCR - Get Free Report) last released its quarterly earnings data on Wednesday, May 7th. The company reported $0.92 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.83 by $0.09. The business had revenue of $3 billion during the quarter, compared to analyst estimates of $2.87 billion. Oscar Health had a return on equity of 2.28% and a net margin of 0.28%. The business's revenue for the quarter was up 42.2% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.62 EPS. Analysts anticipate that Oscar Health, Inc. will post 0.69 earnings per share for the current year.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.